EMAIL THIS PAGE TO A FRIEND

PloS one

In vitro metabolism of 20(R)-25-methoxyl-dammarane-3, 12, 20-triol from Panax notoginseng in human, monkey, dog, rat, and mouse liver microsomes.


PMID 24736630

Abstract

The present study characterized in vitro metabolites of 20(R)-25-methoxyl-dammarane-3β, 12β, 20-triol (20(R)-25-OCH3-PPD) in mouse, rat, dog, monkey and human liver microsomes. 20(R)-25-OCH3-PPD was incubated with liver microsomes in the presence of NADPH. The reaction mixtures and the metabolites were identified on the basis of their mass profiles using LC-Q/TOF and were quantified using triple quadrupole instrument by multiple reaction monitoring. A total of 7 metabolites (M1-M7) of the phase I metabolites were detected in all species. 25(R)-OCH3-PPD was metabolized by hydroxylation, dehydrogenation, and O-demethylation. Enzyme kinetic of 20(R)-25-OCH3-PPD metabolism was evaluated in rat and human hepatic microsomes. Incubations studies with selective chemical inhibitors demonstrated that the metabolism of 20(R)-25-OCH3-PPD was primarily mediated by CYP3A4. We conclude that 20(R)-25-OCH3-PPD was metabolized extensively in mammalian species of mouse, rat, dog, monkey, and human. CYP3A4-catalyzed oxygenation metabolism played an important role in the disposition of 25(R)-OCH3-PPD, especially at the C-20 hydroxyl group.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

C4982 Cytochrome P450 human, 3A4 isozyme microsomes, with P450 reductase and cytochrome b5, recombinant, expressed in baculovirus infected insect cells (BTI-TN-5B1-4)
C3735 Cytochrome P450 human, 1A1 Isozyme Microsomes, with P450 Reductase, recombinant, expressed in baculovirus infected insect cells (BTI-TN-5B1-4)
C5614 Cytochrome P450 human, 1A2 Isozyme Microsomes, with P450 Reductase and cytochrome b5, recombinant, expressed in baculovirus infected insect cells (BTI-TN-5B1-4)
C5740 Cytochrome P450 human, 2E1 isozyme microsomes, with P450 Reductase and cytochrome b5, recombinant, expressed in baculovirus infected insect cells (BTI-TN-5B1-4)
C3860 Cytochrome P450 human, 1B1 Isozyme Microsomes, with P450 Reductase, recombinant, expressed in baculovirus infected insect cells (BTI-TN-5B1-4)
C4985 Cytochrome P450 human, 4F2 isozyme microsomes, with P450 Reductase and cytochrome b5, recombinant, expressed in baculovirus infected insect cells (BTI-TN-5B1-4)
C5235 Cytochrome P450 human, 4F3B isozyme microsomes, with P450 Reductase and cytochrome b5, recombinant, expressed in baculovirus infected insect cells (BTI-TN-5B1-4)
K1003
Ketoconazole, 99.0-101.0% (EP, titration)
C26H28Cl2N4O4
PHR1385
Ketoconazole, Pharmaceutical Secondary Standard; Certified Reference Material
C26H28Cl2N4O4
UC280
Ketoconazole
C26H28Cl2N4O4
1356508
Ketoconazole, United States Pharmacopeia (USP) Reference Standard
C26H28Cl2N4O4
K0600000
Ketoconazole, European Pharmacopoeia (EP) Reference Standard
C26H28Cl2N4O4
1592409
Quercetin, United States Pharmacopeia (USP) Reference Standard
C15H10O7 · 2H2O
Q3625
Quinidine, anhydrous
C20H24N2O2
22600
Quinidine, crystallized, ≥98.0% (dried material, NT)
C20H24N2O2
S0758
Sulfaphenazole, ≥98%
C15H14N4O2S
UC166
Sulfaphenazole, ≥98% (HPLC)
C15H14N4O2S